REGISTER
LOG IN
HOME
RESOURCES
Publications
Conference Calendar
Past Quiz Results
ARTICLES
Revisiting ISHAM Asia 2021
The first AFWG CaseClinic is now live!
First-ever Study of Mycology Lab Practices in Asia
New Diagnostic Mycology E-learning Course
Antifungal prophylaxis: Whom, what and when
Fereydounia khargensis: A New Opportunistic Yeast Reported from Malaysia
9 Years of MMTN: Improving Fungal Disease Management in Asia Pacific
Echinocandins: Clinicians' Guide
Five controversies in mycology
Fungemia blood culture media
Deep dermatophytosis
AFWG Education Module 4: Is Antifungal Susceptibility Testing Useful for Clinical Management?
AFWG Education Module 5: TDM of Antifungal Agents - Essential or Optional?
AFWG Education Module 6: Antifungal Stewardship
10 common mistakes in laboratory mycology
Itraconazole: A Quick Guide for Clinicians
Evolving Fungal Landscape in Asia
10 common mistakes in clinical mycology
Laboratory Diagnosis of Pythiosis
ICMR Issues C. auris Advisory
Strengths and Limitations of Imaging for Diagnosis of IFI
Candidemia: Lessons Learned from Asian Studies for Intervention
Spotting invasive pulmonary aspergillosis in COVID-19 patients
Pivotal Asian Invasive Mold Study
Impact of the COVID-19 pandemic on IFI epidemiology and trends
Mycetoma in Asia: Still veiled in mystery
Cryptococcosis
Identifying IFI risk factors in patients with COVID-19
ASID ANZMIG x AFWG: Fungal Frontiers in the Asia Pacific – Webinar 2
New Antifungal Agents
Gilead IFI Masterclass: Current updates on the management of IFIs in immunocompromised hosts
The AFWG Masterclass: Advanced fungal education at your fingertips
A challenging case: A crisis unfolds
The role of antifungal stewardship in improving IFI outcomes
Making Precise Diagnoses: Experience from the Laboratory Skills Enhancement Course
A challenging case: A 68-year-old man with nasal and palatal ulcers
AFWG Online Education Module 3: Optimizing Dosing in IFI Management
AFWG Online Education Module 2: Antifungal Prophylaxis in Solid Organ Transplantation
AFWG Education Module 1: The Value of Clinical Mycology Laboratories
How do I interpret Candida in the urine?
How do I interpret Candida in respiratory tract cultures?
Cryptococcosis in HIV and non-HIV infected patients
Human Pythiosis
AFWGOnline Privacy Policy has been Updated
Management of fungal infections in high-risk patients
Striving for Perfection: Experience from the Laboratory Foundation Training Course
Know your fungal landscape in Vietnam
Recent Advances of Fungal Diagnostics in Asian Laboratories
Deep Dermatophytosis: A Case Report
Management of cryptococcosis and talaromycosis
A challenging case: A 49-year-old woman with sarcoidosis
Emerging yeast infections in Asia
Outbreak of Superbug Candida auris: Asian Scenario and Interventions
Championing Medical Mycology: Thoughts on the AFWG Laboratory Skills Enhancement Course
Mucormycosis and Pythiosis – New Insights
AML and the high risk of multiple infectious complications
Do We Need Modification of Recent IDSA & ECIL Guidelines while Managing Patients in Asia?
A hospital’s experience with candidemia and empirical therapy
Top 5 most viewed AFWG videos on YouTube
Fungal Academy 2015
Fluconazole in 2015
Fungal isolation protocol
Influencing Aspergillus
Fungal Asthma
Aspergillus
Laboratory Diagnosis of IPA
Two-Hot-to-Handle
Voriconazole
Educational Organizations
Literature Updates
 

Articles

Fereydounia Khargensis: A New Opportunistic Yeast Reported From Malaysia

Share this
page



Share
this page

Ms Ratna Mohd Tap and Dr Fairuz Amran
Mycology Laboratory
Infectious Diseases Research Centre
Institute for Medical Research
Kuala Lumpur, Malaysia

Fereydounia khargensis represents a new lineage in the order Urocystales, subphylum Ustilaginomycotina. It was first discovered in Iran in 20141; in 2016, RM Tap et al reported 2 invasive infections caused by F. khargensis in immunocompromised patients in Malaysia, which are discussed below.2

The first case of F. khargensis was from an HIV-positive patient. He was admitted because of episodes of fever associated with chills and rigors for 2 weeks. The patient was initially treated with amphotericin B, but the clinical condition did not improve. Antifungal treatment was changed to itraconazole and he was discharged upon improvement.

The second case was a hepatitis B carrier with hypertension, diabetes mellitus and end-stage renal failure on continuous ambulatory peritoneal dialysis (CAPD). He was admitted because of a dislodged distal connector of his Tenckhoff catheter caused by a fall in the toilet. After the incident, the dislodged connector was reconnected to the Tenckhoff catheter and used for CAPD. Fluconazole was started following yeast growth from the peritoneal fluid. The clinical condition of the patient improved after fluconazole treatment.

Both cases grew yeast-like colonies. Figures 1 and 2 show the macro- and microscopic examinations. Results from API 20C AUX and VITEK 2 identification system were Cryptococcus neoformans (98% probability) and Cryptococcus laurentii (89% probability), respectively. Internal transcribed spacer (ITS) and D1/D2 region in large subunit (LSU) of rRNA gene were amplified using universal primers and sequenced. Both F. khargensis isolates matched 99.7% (ITS) and 100.0% (LSU) to the reference strain, IBRC-M 30116.

Figure 1. F. khargensis colonies on Sabouraud dextrose agar (SDA) after 48 h incubation at 30°C presented as cream-colored colonies, dry and wrinkled (a). However, after 72 h of incubation, the colonies started producing melanin-like pigmentation, which turned even darker after 120 h (b).

Figure 2. Elongated and irregular shape of F. khargensis yeast cells from 48 h SDA plate. The length of the cells ranged from 5.63 to 18.34 μm. Magnification at x40 (a) and x100 (b).

In vitro susceptibility testing showed that itraconazole and voriconazole have good activity against the yeast with minimum inhibitory concentration (MIC) ranging from 0.032 to 2.000 µg/mL, but MIC was slightly higher for fluconazole (8.000 µg/mL). On the other hand, both isolates showed resistance to amphotericin B, caspofungin and anidulafungin with the MIC more than 32.000 µg/mL.

In summary, F. khargensis is a new and uncommon opportunistic yeast. The incidence of rare fungal pathogens is rapidly increasing due to the expanding population of immunocompromised patients and advanced identification techniques. In this report, low CD4 count (case 1) and complicated medical conditions (case 2) are the risk factors that predisposed the patients to F. khargensis infection. Observation of macroscopic and microscopic characteristics provides clues to their atypical features. Correct identification is crucial and can be made possible by polymerase chain reaction (PCR) sequencing. F. khargensis exhibited resistance to polyenes and echinocandin but was sensitive to azoles.

References

  1. Nasr S, Soudi MR, Fazeli SAS, et al. Expanding evolutionary diversity in the Ustilaginomycotina: Fereydouniaceae fam. nov. and Fereydounia gen. nov., the first urocystidalean yeast lineage. Mycol Prog 2014;13:1217-1226.
  1. Tap RM, Ramli NY, Sabaratnam P, et al. First two cases of fungal infections associated with multi-drug resistant yeast, Fereydounia khargensis. Mycopathologia 2016;181:531-537.
SIGN UP FOR NEWSLETTER
SIGN UP

This field is required. Please enter your email address.
Thank you for signing up for the AFWG newsletter.
Your subscription has been updated.